trial · primary record
DNX-2401
Melanoma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 50 |
| Primary completion | 2029-01-30 |
| Primary endpoint | Safety and Adverse Events (AEs) |
| Registry ID | NCT07444606 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:10.695Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07444606
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.